IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 195 filers reported holding IMMUNOGEN INC in Q4 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $194,852 | -41.0% | 12,278 | -29.9% | 0.00% | -42.9% |
Q2 2023 | $330,433 | +325.0% | 17,511 | +11.7% | 0.01% | +250.0% |
Q4 2022 | $77,743 | +3.7% | 15,674 | -0.0% | 0.00% | 0.0% |
Q3 2022 | $75,000 | -12.8% | 15,676 | -17.6% | 0.00% | -33.3% |
Q2 2022 | $86,000 | +17.8% | 19,026 | +23.8% | 0.00% | +50.0% |
Q1 2022 | $73,000 | -36.0% | 15,374 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $114,000 | +31.0% | 15,374 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $87,000 | -20.9% | 15,374 | -8.0% | 0.00% | -20.0% |
Q2 2021 | $110,000 | -79.4% | 16,712 | -74.7% | 0.01% | -79.2% |
Q1 2021 | $535,000 | +302.3% | 66,040 | +219.6% | 0.02% | +500.0% |
Q4 2020 | $133,000 | +60.2% | 20,661 | -10.7% | 0.00% | +33.3% |
Q3 2020 | $83,000 | -94.0% | 23,126 | -92.4% | 0.00% | -92.9% |
Q2 2020 | $1,393,000 | +295.7% | 302,829 | +193.3% | 0.04% | +320.0% |
Q1 2020 | $352,000 | -15.2% | 103,246 | +26.9% | 0.01% | +25.0% |
Q4 2019 | $415,000 | -77.8% | 81,364 | -66.6% | 0.01% | -70.4% |
Q3 2017 | $1,866,000 | – | 243,949 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 13,063,767 | $35,403,000 | 1.04% |
QVT Financial LP | 1,375,900 | $3,442,000 | 0.87% |
Virtus ETF Advisers LLC | 50,045 | $136,000 | 0.29% |
Fernwood Investment Management, LLC | 187,000 | $507,000 | 0.27% |
PURA VIDA INVESTMENTS, LLC | 524,600 | $1,422,000 | 0.20% |
Endurant Capital Management LP | 184,440 | $500,000 | 0.20% |
Birchview Capital, LP | 90,000 | $244,000 | 0.15% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 112,873 | $306,000 | 0.14% |
DLD Asset Management, LP | 1,239,500 | $3,347,000 | 0.12% |
DLD Asset Management, LP | 1,186,300 | $3,215,000 | 0.12% |